angiogenesis inhibitor

Term ID

CHEBI:48422

Synonyms

angiogenesis antagonist
angiostatic agents
anti-angiogenic agent

Definition

An agent and endogenous substances that antagonize or inhibit the development of new blood vessels.

References

Wikipedia:Angiogenesis_inhibitor

Ontology

ChEBI ( EBI )

Relationships

is a type of: drug

drug Show first 5 Terms
inverse has_role: (-)-antofine (-)-matairesinol (-)-voacangine (1R,2S,3S,4S)-4-formyl-2-methoxy-3-[(2E)-6-methylhept-2-en-2-yl]cyclohexyl (2E)-3-(4-methoxyphenyl)acrylate (1S,2S,3S)-3-methoxy-2-[(2E)-6-methylhept-2-en-2-yl]-4-oxocyclohexanecarbaldehyde ... Show All 95 Terms

(-)-antofine (-)-matairesinol (-)-voacangine (1R,2S,3S,4S)-4-formyl-2-methoxy-3-[(2E)-6-methylhept-2-en-2-yl]cyclohexyl (2E)-3-(4-methoxyphenyl)acrylate (1S,2S,3S)-3-methoxy-2-[(2E)-6-methylhept-2-en-2-yl]-4-oxocyclohexanecarbaldehyde (2S,3S,4S)-2-methoxy-3-[(2E)-6-methylhept-2-en-2-yl]-4-(trifluoroacetyl)cyclohexanone (2S,3S,4S)-4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-2-methoxy-3-[(2E)-6-methylhept-2-en-2-yl]cyclohexanone (2S,3S,4S)-4-(hydroxymethyl)-2-methoxy-3-[(2E)-6-methylhept-2-en-2-yl]cyclohexanone (2S,3S,4S)-4-acetyl-2-methoxy-3-[(2E)-6-methylhept-2-en-2-yl]cyclohexanone (4Z,7Z,10Z,12E,14S,16Z,19Z,21R)-dihydroxydocosahexaenoic acid 2-amino-3-cyano-7-(dimethylamino)-4-(2-methoxyphenyl)-4H-chromene 3PO AEE788 ageladine A amentoflavone anisotanol C AR-42 ascochlorin ascofuranone aureothricin baicalein batimastat brivanib brivanib alaninate cafestol CAN-508 capsiate CHIR-265 cratoxylumxanthone C crenolanib deguelin diosmetin disulfiram DMH4 EG00229 epoxytwinol A fumagillin givinostat givinostat hydrochloride givinostat hydrochloride monohydrate GP369 GSK126 herbacetin indirubin JQ1 kahweol LDN-212854 lenalidomide leucosesterlactone leucosesterterpenone linifanib luminespib lupulone luteolin menadione meso-tetrakis(N-methyl-4-pyridyl)porphine tetrakis(p-toluenesulfonate) meso-tetrakis(N-methyl-4-pyridyl)porphine(4+) MP-A08 N-(5-{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl}-1,3-thiazol-2-yl)piperidine-4-carboxamide N-[3-(aminomethyl)benzyl]acetamidine nintedanib nintedanib esylate NNC 55-0396 (free base) NNC 55-0396 dihydrochloride nomilin O-(chloroacetylcarbamoyl)fumagillol oridonin PD-166866 PF-573228 PJ34 PJ34 hydrochloride plinabulin pomalidomide quininib quininib hydrochloride rifampicin SB220025 SH-11037 sorafenib SU4312 sunitinib suramin suramin sodium tamoxifen tamoxifen citrate tasisulam telatinib thalidomide thiolutin toluquinol trans-rhaponticin TW-37 vatalanib vatalanib succinate wogonin Show first 5 Terms

Phenotype

Phenotype resulting from angiogenesis inhibitor

Phenotype where environments contain angiogenesis inhibitor

Phenotype modified by environments containing angiogenesis inhibitor

Human Disease Model